Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Adherence, Persistence and Efficacy of Treatment With Alirocumab 300mg in Italy - The ALINET Registry

NCT07375225 is registered in ClinicalTrials.gov with Federico II University as lead sponsor.

NCT NCT07375225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07375225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Adherence, Persistence and Efficacy of Treatment With Alirocumab 300mg in Italy - The ALINET Registry
Lead sponsor
Federico II University
Phase
Observational
Overall status
Recruiting
Start date
December 1, 2024
Completion date
December 1, 2027
Enrollment
1,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolaemia